Date:2/24/2012

growth from the Services segment in 2012 and beyond from an expanding set of partnerships in our Endocare® cryoablation therapy as well as our pilot programs involving the sales of this device through the AMS channel.  In the fourth quarter of 2011, HealthTronics Inc., completed the strategic acquisitions of Intuitive Medical Software (IMS) and meridianEMR, Inc., two providers of electronic medical records for urologists, that provide access to approximately 1,850 urologists using data platforms that will enhance service offerings in urology practice management.  

Balance Sheet UpdateDuring the fourth quarter of 2011, Endo made payments of approximately $140 million to reduce the outstanding principal of term-loan debt associated with the acquisition of AMS.  For the full year ending Dec. 31, 2011, Endo made payments of approximately $290 million to reduce the outstanding principal of term-loan debt associated with the acquisition of AMS.  At Dec. 31, 2011, the company's debt to adjusted EBITDA ratio is 3.0 times.  The company believes that it will achieve its objective of reducing its debt to adjusted EBITDA ratio to 2.0 to 2.5 times in 2013.

2012 FINANCIAL GUIDANCEEndo's estimates are based on projected results for the twelve months ended Dec. 31, 2012.  The company's guidance for reported (GAAP) earnings per share does not include any estimates for the potential future changes in the fair value of contingent consideration, certain separation benefits, asset impairment charges or for potential new corporate development transactions.  For the full year ended Dec. 31, 2012, Endo estimates:

Total revenue between $3.15 billion and $3.30 billion

Total Branded Pharmaceuticals segment revenue between $1.740 billion and $1.800 billion

Total Generics segment revenue between $635 million and $675 million

Total Devices segment revenue between $530 million and $570 million

Tota
'/>"/>

SOURCE Endo Pharmaceuticals Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
Related medicine technology :

1. Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
2. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
3. Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference
4. Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update
5. Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
6. Arena Pharmaceuticals to Present at the Citi 2012 Global Health Care Conference
7. Satori Pharmaceuticals Raises $15M in New Funding
8. Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for XIAFLEX® in Canada, Australia, Brazil and Mexico
9. Onyx Pharmaceuticals Completes Enrollment in ASPIRE Phase 3 Carfilzomib Combination Trial for the Potential Treatment of Relapsed Multiple Myeloma
10. Endo Pharmaceuticals to Present at Cowen & Co. 32nd Annual Health Care Conference
11. Idenix Pharmaceuticals to Present at the Citi Global Healthcare Conference